Lovesac (LOVE) director adds 6,308 shares, receives 7,947 new RSUs

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Lovesac Co director Walter Field McLallen increased his equity stake through routine equity compensation. He acquired 6,308 shares of common stock at $0.00 per share upon vesting of restricted stock units that were originally granted on June 10, 2025. Following this vesting, he directly holds 46,308 common shares.

Separately, McLallen received a new grant of 7,947 restricted stock units, each representing the right to receive one share of common stock upon vesting. The filing states that 100% of this new RSU grant is scheduled to vest on June 9, 2027. No open-market purchases or sales were reported.

Insider Trade Summary

6,308 shares exercised/converted

Mixed 3 txns

Insider McLallen Walter Field

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	6,308	$0.00	--
Grant/Award	Common Stock, $0.00001 par value	6,308	$0.00	--
Grant/Award	Restricted Stock Units	7,947	$0.00	--

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock, $0.00001 par value — 46,308 shares (Direct, null)

Footnotes (1)

The reported shares were acquired upon the vesting of RSUs granted to the Reporting Person on June 10, 2025. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The Reporting Person received a grant of RSUs of which 100% are subject to vesting on June 9, 2027.

Key Figures

Shares acquired via RSU vesting: 6,308 shares Total common shares after transactions: 46,308 shares New RSU grant: 7,947 RSUs +2 more

5 metrics

Shares acquired via RSU vesting 6,308 shares Common stock received at $0.00 per share

Total common shares after transactions 46,308 shares Direct holdings following RSU vesting

New RSU grant 7,947 RSUs Grant reported with 100% vesting on June 9, 2027

RSU conversion price $0.00 per share Exercise/conversion price for 6,308 RSUs into common stock

RSU vesting date for new grant June 9, 2027 Date when 7,947 RSUs are scheduled to vest 100%

Key Terms

Restricted Stock Units, vesting, contingent right

3 terms

Restricted Stock Units financial

"The Reporting Person received a grant of RSUs of which 100% are subject to vesting on June 9, 2027."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vesting financial

"The reported shares were acquired upon the vesting of RSUs granted to the Reporting Person on June 10, 2025."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

contingent right financial

"Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/10/2026 - 05:56 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McLallen Walter Field

(Last)

(First)

(Middle)

C/O THE LOVESAC COMPANY

421 ATLANTIC STREET, SUITE 201

(Street)

STAMFORD

CONNECTICUT

06901

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Lovesac Co [ LOVE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, $0.00001 par value	06/10/2026		A		6,308⁽¹⁾	A	$0	46,308	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽²⁾	06/09/2026		A		7,947		⁽³⁾	⁽³⁾	Common Stock	7,947	$0	7,947	D
Restricted Stock Units	$0⁽²⁾	06/10/2026		M			6,308	⁽¹⁾	⁽¹⁾	Common Stock	6,308	$0	0	D

Explanation of Responses:

1. The reported shares were acquired upon the vesting of RSUs granted to the Reporting Person on June 10, 2025.

2. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.

3. The Reporting Person received a grant of RSUs of which 100% are subject to vesting on June 9, 2027.

Remarks:

	/s/ Megan C. Preneta, as Attorney-in-Fact for Walter McLallen	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Lovesac (LOVE) director Walter Field McLallen report in this Form 4?

Walter Field McLallen reported routine equity compensation changes. He acquired 6,308 Lovesac common shares through RSU vesting and received a new grant of 7,947 restricted stock units, with no open-market buying or selling disclosed in this filing.

How many Lovesac (LOVE) shares does Walter Field McLallen hold after these transactions?

After the reported transactions, Walter Field McLallen directly holds 46,308 shares of Lovesac common stock. This reflects the addition of 6,308 shares received at $0.00 per share upon vesting of restricted stock units granted in June 2025.

What restricted stock unit (RSU) activity did Lovesac (LOVE) disclose for Walter Field McLallen?

The filing shows 6,308 RSUs converted into Lovesac common shares at $0.00 per share and a new award of 7,947 RSUs. Each RSU represents a contingent right to receive one common share upon vesting, according to the disclosure language.

When will Walter Field McLallen’s new Lovesac (LOVE) RSU grant vest?

The new grant of 7,947 restricted stock units to Walter Field McLallen is scheduled to vest 100% on June 9, 2027. At vesting, each RSU entitles him to receive one share of Lovesac common stock, subject to the award terms.

Did the Lovesac (LOVE) Form 4 show any open-market stock sales or purchases?

The Form 4 does not show any open-market sales or purchases. All reported changes come from RSU vesting into 6,308 common shares at $0.00 per share and a new grant of 7,947 RSUs, which are compensation-related transactions.